Why Some People With Herpes Never Get Sores: A New Skin-Cell Clue
Why do some people with genital herpes get painful outbreaks several times a year, while others carry the same virus for decades and never notice a single sore? A small new laboratory study from Fred Hutch Cancer Center and the University of Washington points to a surprising part of the answer: the skin cells themselves. The research, published in PLOS Pathogens and highlighted by Fred Hutch on November 18, 2026, found that skin cells from people with no herpes symptoms reacted much more strongly to a key immune alarm signal than skin cells from people with frequent outbreaks.
It is early, basic science, not a new test or treatment. But for anyone who has asked "why me?" or "why did my partner never have symptoms?", it offers a clearer, stigma-free picture of how differently the same virus can behave from one body to the next.
What the researchers studied
Herpes simplex virus type 2 (HSV-2) first infects skin and mucosal cells, then settles into nearby nerve cells, where it stays for life. From time to time it reactivates and travels back to the skin. When that happens, some people develop sores, while in others the virus is shed with no symptoms at all.
The team, led by first author Angelina Zimenko and senior author Jia Zhu in the Zhu and Corey labs, focused on a signal called interferon gamma (IFN-γ). Immune cells that stand guard in the skin, known as tissue-resident memory T cells, release IFN-γ to help control herpes when it wakes up. The researchers wanted to know whether skin cells respond to that signal differently in people with and without symptoms.
- Who took part: 10 adults with HSV-2 recruited through the University of Washington Virology Research Clinic in Seattle. Five had no history of genital herpes episodes (asymptomatic), and five had recurrent sores, with 6 or more outbreaks a year. None had HIV or other known immune-weakening conditions.
- What was tested: Keratinocytes (the main cells of the outer skin layer, and the cells herpes infects first) and fibroblasts (deeper connective-tissue cells) grown from each person's skin samples.
- How: The cells were exposed to different amounts of IFN-γ in the lab, and the researchers measured which immune genes and proteins switched on.
What they found
- Skin cells are very sensitive to the alarm signal. Keratinocytes reacted to amounts of IFN-γ far lower than those used in earlier studies, and much more strongly than fibroblasts from the same people. According to Fred Hutch, CXCL10, a chemokine (a small signaling protein that directs immune cells where to go), rose by an average of 8,941-fold in keratinocytes, compared with 410-fold in fibroblasts.
- The biggest difference was between people with and without symptoms. At the lowest dose tested, CXCL10 rose roughly 1,000-fold on average in skin cells from people without symptoms, versus about 40-fold in cells from people with recurrent sores. Related signals, including CXCL11, followed the same pattern.
- The difference disappeared at high doses. When the cells got large amounts of IFN-γ, the two groups looked similar. The researchers suggest that the high doses used in earlier studies may have hidden this effect.
- Both groups blocked the virus equally well in the dish. Pretreating the cells with IFN-γ limited herpes growth about the same in both groups. So the key difference may not be how well skin cells fight the virus directly, but how well they call immune cells to the right spot.
The authors propose a simple model: in some people, a small amount of IFN-γ from a few guard T cells may be enough to make skin cells send out a strong recruiting signal, drawing more immune cells in to contain the reactivated virus before a sore forms. In the study's background, the authors note that about half of HSV-2 shedding episodes are contained within 6 to 18 hours, while others last more than a week.
In the Fred Hutch article, Dr. Zhu said the findings "expand the current view of antiviral immunity by showing that structural cells are not merely passive targets of infection."
Important limits
- It was very small. Only 10 people took part, and the authors list the small number of participants as a limitation.
- It was done in lab dishes. Cells grown in a dish don't fully reflect what happens in living skin, where many cell types interact. The authors call for more realistic models and further studies.
- It shows an association. The study links stronger skin-cell responses with having no symptoms. It doesn't prove this is the only reason, or the main reason, some people never get sores.
- Nothing changes in care yet. There is no test that measures this response, and no product that can "boost" it. The authors say the work could one day help guide new treatments and vaccines. There is still no cure or approved vaccine for genital herpes.
Why this matters for people with herpes
Many people blame themselves for frequent outbreaks, or feel confused when a partner who passed herpes to them never had a symptom. This study adds to the evidence that how herpes shows up depends partly on each person's own immune biology, not on hygiene, character or "doing something wrong."
It also fits what public health agencies already say. According to the CDC, most people with genital herpes have no symptoms or very mild symptoms, and many don't know they have it. We explain more in why most people with herpes never know they have it and whether genital herpes can cause symptoms without sores. To understand how the virus rests and wakes up, see how long herpes can stay dormant and how stress can trigger outbreaks.
The study also connects to a broader research push to use the skin's own guard cells against herpes, which we covered in the "prime and pull" herpes vaccine approach.
What it means if you're dating
- No symptoms doesn't mean no risk. The CDC notes that genital herpes can be passed by a partner who has no visible sore or doesn't know they have it. People without outbreaks can still shed the virus, so the usual ways of lowering risk still matter. Our guide to asymptomatic spread and protection walks through the basics.
- Talk with a clinician about your options. Daily antiviral medicine can reduce outbreaks and lower the chance of passing herpes to a partner. Read what suppressive therapy can and can't do, and ask a licensed provider whether it fits your situation.
- Your body's pattern is not a measure of your worth. Whether you get frequent outbreaks or none, you can have a full, loving dating life. If you're getting ready to talk about your status, our guide on when to tell someone you have herpes can help.
And if you'd like to meet people who already understand, explore herpes dating on MeetPositives.
Sources
- Zimenko A, Hayman I, Fong Y, Monroe LD, Mills MG, Greninger A, Johnston C, Corey L, Zhu J. "Epithelial interferon-γ responsiveness shapes chemokine induction and clinical outcomes in herpes simplex virus infection." PLOS Pathogens, 2026;22(9):e1014612. doi:10.1371/journal.ppat.1014612
- Alleman E. "Sore or silent: why do herpes outcomes differ?" Fred Hutch Cancer Center, November 18, 2026.
- Centers for Disease Control and Prevention. "About Genital Herpes."
This article is for general information only and is not medical advice. It does not create a doctor-patient relationship. Talk with a licensed health care provider about your own situation.
Share This Story, Choose Your Platform!
About the author
Staff Writer
Comments (0)
Ask A Question
Have A Question, Personal Story, Or Situation You'd Like Help With? Share It Here. The More Context You Include, The More Thoughtful And Useful Our Guidance Can Be.
Our Editorial Team (And Occasional Relationship Contributors) May Choose Selected Submissions To Answer In An Upcoming Blog Post. All Submissions Are Reviewed And Published Anonymously—We Will Never Include Identifying Details.
Important:
If Your Question Is About Your Account, Billing, Upgrades, Reports, Or Technical Issues, Please Contact Customer Care Through The Help Pages So We Can Assist You Faster.
Tips For A Better Answer (Optional):
- Your Age Range + What You're Looking For (Dating, Friendship, Support)
- What You've Tried So Far
- What You're Hoping Happens Next
- Any Boundaries Or Dealbreakers You Want Respected
Responses Shared Here Are For General Information Only And Aren't Medical, Legal, Or Mental-Health Advice.
We Can't Provide Real-Time Or One-On-One Support Through This Form.

